adorable baby smiling with joy
Peds Calc

PedsCalc Pro

No ads, plus saved calculations and notes in the Pro app.

$19.99/year, about $1.67/month. Cancel anytime.

Safety Information

Albendazole Contraindications & InteractionsWhen Not to Use & Important Drug Interactions

Review pregnancy status, hepatic reserve, and concomitant medications before starting albendazole. Ongoing monitoring keeps prolonged regimens safe.

Clinical Utility: 9/10
3 Clinical Sources
Back to Albendazole Overview

Absolute contraindications include hypersensitivity to benzimidazoles, pregnancy during the first trimester, and active bone marrow suppression. Relative cautions include chronic liver disease, breastfeeding, concomitant hepatotoxic or myelosuppressive drugs, and enzyme-inducing anticonvulsants that lower drug exposure.

Contraindications

Absolute Contraindications (Never Use)

First-trimester pregnancy

Albendazole is teratogenic in animal studies; human data remain limited but precaution favored.

Baseline marrow suppression

Albendazole can worsen leukopenia and lead to infection risk.

Relative Contraindications (Use With Caution)

Chronic liver disease / elevated transaminases

Albendazole undergoes hepatic metabolism; injury risk increases when baseline AST/ALT elevated.

If used, monitor: Obtain baseline AST/ALT, repeat every 2 weeks during therapy >7 days, hold drug if >2x baseline.

Breastfeeding

Metabolites appear in milk; risk to infant appears low but data limited.

If used, monitor: Short single doses considered compatible; for prolonged courses consider pumping and discarding for 5 days or switching to formula temporarily.

Concurrent anticonvulsants (phenytoin, carbamazepine, phenobarbital)

Induce hepatic enzymes lowering albendazole sulfoxide levels and treatment success.

If used, monitor: Consult infectious disease for dose adjustment or consider switching to praziquantel/nitazoxanide when feasible.

Pregnancy & Lactation

Avoid in first trimester; second/third trimester use only when benefits outweigh risks and ideally alongside obstetric consult. Short single doses acceptable; pump-and-dump for 5 days after long courses if feasible.

Drug Interactions

Cimetidine

moderate interaction

Specific drugs: Cimetidine

Effect: Higher risk of hepatotoxicity during prolonged therapy

How it happens: Inhibits hepatic metabolism raising albendazole sulfoxide levels

Management: Avoid or switch to alternative acid suppression (famotidine, PPI); monitor LFTs more frequently

Dexamethasone

moderate interaction

Specific drugs: Dexamethasone

Effect: Potential hepatic injury if other risks present

How it happens: Increases albendazole sulfoxide exposure—beneficial for CNS penetration but adds hepatic load

Management: Use lowest effective steroid dose, track LFTs

Anticonvulsants (phenytoin, carbamazepine, phenobarbital)

moderate interaction

Specific drugs: Anticonvulsants (phenytoin, carbamazepine, phenobarbital)

Effect: Reduced efficacy, persistent cyst burden

How it happens: Induce CYP enzymes lowering active metabolite levels

Management: Adjust albendazole dose per ID/neurology guidance or choose alternate therapy

Praziquantel

moderate interaction

Specific drugs: Praziquantel

Effect: Higher risk of fever, hepatotoxicity

How it happens: Competes for metabolism; coadministration may raise levels of both drugs

Management: Stagger administration when possible and increase monitoring

Allergy Assessment

True Allergy Signs

  • Immediate hives, angioedema, or bronchospasm
  • Generalized exfoliative rash or blistering
  • Hypotension or syncope after dosing

Non-Allergic Reactions

  • Mild nausea or headache within 24 hours
  • Transient hair thinning during long courses
  • Localized itching without rash

History Questions

  • Which benzimidazole caused the reaction?
  • How long after the dose did symptoms appear?
  • Were steroids or epinephrine required?

Cross-Reactivity Notes

  • History of severe reaction to mebendazole increases likelihood of albendazole hypersensitivity
  • Topical benzimidazole exposure (veterinary use) can occasionally prime allergic responses

Special Populations

Pregnancy

Avoid in first trimester; second/third trimester use only when benefits outweigh risks and ideally alongside obstetric consult.

Breastfeeding

Short single doses acceptable; pump-and-dump for 5 days after long courses if feasible.

Hepatic Impairment

Start at lower dose or extend dosing interval; mandatory LFT monitoring.

Hematologic Disorders

Baseline and q2 week CBC for any therapy beyond 5 days.

Safety Screening Tools

Emergency Situations

Emergency scenario

Use: Avoid if possible

Emergency scenario

Use: Avoid if possible

Monitoring

Baseline Guidance

  • Pregnancy test and contraception counseling
  • AST/ALT, bilirubin, CBC with differential
  • Eye exam for suspected neurocysticercosis
  • Neuro exam and imaging when treating CNS disease

During Therapy

  • LFTs and CBC every 2 weeks for regimens ≥7 days
  • Monitor for headache, visual changes, or seizures when CNS lesions present
  • Assess adherence to fat-containing meals and sanitation plans

Red Flags

  • New jaundice, dark urine, or RUQ tenderness
  • Fever or sore throat suggesting neutropenia
  • Severe headache with vomiting in neurocysticercosis patients

Parent Communication Guide

Key Safety Messages

  • Albendazole is safe when taken exactly as prescribed with a fatty meal.
  • Report yellow eyes, dark urine, or unexplained bruising immediately.
  • A second dose (day 14) or lab checks may be part of the plan—set reminders now.

Monitoring Checklist

  • Note the food eaten with each dose
  • Record any headaches, fevers, or rashes
  • Bring lab slips/logs to follow-up appointments

When to Call

Vomiting or headache that will not resolve

Within hours

Fever or sore throat while on long courses

Within hours

Possible pregnancy exposure

Within hours

Alternative Options

Mebendazole

Use case: Pinworm, hookworm when albendazole unavailable

Lower systemic absorption—less effective for tissue disease

Nitazoxanide

Use case: Giardiasis or when benzimidazoles contraindicated

Well tolerated; requires BID dosing

Ivermectin

Use case: Strongyloidiasis or scabies co-infections

Not interchangeable for tissue cestodes

Clinical Pearls

Counsel families that transient hair thinning can occur during prolonged albendazole courses—anticipatory guidance prevents unnecessary discontinuation.

Evidence: Not specifiedSource: Unknown

Track doses with a shared log when multiple household members are treated simultaneously to avoid double dosing.

Evidence: Not specifiedSource: Unknown

Clinical References

CDC Clinical Overview of Soil-Transmitted Helminths•Centers for Disease Control and Prevention (2024)guideline
IDSA Clinical Practice Guidelines for Neurocysticercosis•Clinical Infectious Diseases (2021)guideline